Form 8-K - Current report:
SEC Accession No. 0001437749-25-005951
Filing Date
2025-03-03
Accepted
2025-03-03 17:15:38
Documents
14
Period of Report
2025-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20250228_8k.htm   iXBRL 8-K 28208
  Complete submission text file 0001437749-25-005951.txt   164925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20250227.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20250227_def.xml EX-101.DEF 11806
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20250227_lab.xml EX-101.LAB 15857
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20250227_pre.xml EX-101.PRE 12021
16 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20250228_8k_htm.xml XML 2955
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 25699551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)